Consequences of linker length alteration of the α7 nicotinic acetylcholine receptor (nAChR) agonist, SEN12333

Bioorg Med Chem Lett. 2012 Apr 1;22(7):2380-4. doi: 10.1016/j.bmcl.2012.02.052. Epub 2012 Feb 24.

Abstract

A series of ligands based on SEN12333, containing either contracted or elongated alkyl chains, were synthesized and evaluated in molecular docking studies against a homology model of the α7 nicotinic acetylcholine receptor (nAChR) subtype. The predicted binding of all ligands was highly similar, with the exception of the analog containing a 5 methylene unit spacer. However, in vitro competition binding assays revealed that the ligands possessed dissimilar binding affinities, with a K(i) range of more than an order of magnitude (K(i)=0.50 to >10 μM), and only SEN12333 itself exhibited functional activity at the α7 nAChR.

MeSH terms

  • Binding Sites
  • Computer Simulation
  • Humans
  • Kinetics
  • Ligands
  • Models, Molecular
  • Morpholines / chemical synthesis*
  • Morpholines / metabolism
  • Nicotinic Agonists / chemical synthesis*
  • Nicotinic Agonists / metabolism
  • Protein Binding
  • Pyridines / chemical synthesis*
  • Pyridines / metabolism
  • Receptors, Nicotinic / chemistry
  • Receptors, Nicotinic / metabolism
  • alpha7 Nicotinic Acetylcholine Receptor

Substances

  • 5-morpholin-4-ylpentanoic acid (4-pyridin-3-ylphenyl)amide
  • Chrna7 protein, human
  • Ligands
  • Morpholines
  • Nicotinic Agonists
  • Pyridines
  • Receptors, Nicotinic
  • alpha7 Nicotinic Acetylcholine Receptor